Guardant Health Inc’s recent filing unveils that its Director Joyce Meghan V. acquired Company’s shares for reported $4271.0 on Mar 03 ’25. In the deal valued at $42.71 per share,100 shares were bought.
Then, Tariq Musa sold 116 shares, generating $5,606 in total proceeds. Upon selling the shares at $48.33, the Director now owns 3,078 shares.
Before that, Tariq Musa bought 116 shares. Guardant Health Inc shares valued at $5,606 were divested by the Director at a price of $48.33 per share.
Barclays initiated its Guardant Health Inc [GH] rating to an Overweight in a research note published on January 23, 2025; the price target was $60. A number of analysts have revised their coverage, including Guggenheim’s analysts, who increased its forecast for the stock in late June from “a Neutral” to “a Buy”.
Price Performance Review of GH
On Tuesday, Guardant Health Inc [NASDAQ:GH] saw its stock jump 1.82% to $41.48. Over the last five days, the stock has gained 2.80%. Guardant Health Inc shares have risen nearly 35.78% since the year began. Nevertheless, the stocks have risen 121.46% over the past one year. While a 52-week high of $50.89 was reached on 01/30/25, a 52-week low of $15.81 was recorded on 01/02/25. SMA at 50 days reached $40.97, while 200 days put it at $31.24.
Levels Of Support And Resistance For GH Stock
The 24-hour chart illustrates a support level at 39.57, which if violated will result in even more drops to 37.67. On the upside, there is a resistance level at 42.98. A further resistance level may holdings at 44.49. The Relative Strength Index (RSI) on the 14-day chart is 44.68, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at -2.76, which suggests price will go down in the next trading period. Percent R suggests that price movement has been bearish at 78.47%. Stochastics %K at 16.64% indicates the stock is a buying.
The most recent change occurred on December 14, 2023 when Guggenheim began covering the stock and recommended ‘”a Neutral”‘ rating.
